Article Information
History
- February 1, 2024.
Article Versions
- Version 1 (February 6, 2022 - 20:06).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Emily S. Ford1,2,
- Alvason Li1,
- Kerry J. Laing2,
- Lichun Dong2,
- Kurt Diem3,
- Lichen Jing2,
- Krithi Basu2,
- Mariliis Ott2,
- Jim Tartaglia4,
- Sanjay Gurunathan4,
- Jack L. Reid5,
- Matyas Ecsedi5,
- Aude G. Chapuis5,
- Meei-Li Huang3,
- Amalia S. Magaret1,3,
- Christine Johnston1,2,
- Jia Zhu1,3,
- David M. Koelle1,2,3,6,7 and
- Lawrence Corey1,2,3,*
- 1Vaccine and Infectious Diseases Division, Fred Hutch Cancer Center, Seattle WA
- 2Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle WA
- 3Department of Laboratory Medicine and Pathology, University of Washington, Seattle WA
- 4Sanofi Pasteur, Swiftwater PA
- 5Clinical Research Division, Fred Hutch Cancer Center, Seattle WA
- 6Department of Global Health, University of Washington, Seattle WA
- 7Benaroya Research Institute, Seattle WA
- ↵*Corresponding author; email: lcorey{at}fredhutch.org
Posted February 01, 2024.
Expansion of the HSV-2-specific T cell repertoire in skin after immunotherapeutic HSV-2 vaccine
